Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study.
CONCLUSIONS: HAIC with mFOLFOX yielded significantly better treatment responses and less serious toxicity than did TACE. HAIC might represent a feasible and promising first-line treatment for patients with massive unresectable HCC.
PMID: 29061175 [PubMed - in process]
Source: Chinese Journal of Cancer - Category: Cancer & Oncology Tags: Chin J Cancer Source Type: research
More News: Alcoholism | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | China Health | Eloxatin | Hepatocellular Carcinoma | Liver | Liver Cancer | Study | Toxicology | Urology & Nephrology